SUSRF OTC
Surgical Science Sweden AB
1W: +0.0%
1M: +0.0%
3M: +30.0%
YTD: +52.5%
1Y: -46.5%
3Y: -67.8%
$5.20
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$80M
-42.0% ▼
5Y CAGR: +27.9%
Capital Expenditures
$12M
+75.5% ▲
5Y CAGR: +6.0%
Free Cash Flow
$68M
-24.2% ▼
5Y CAGR: +36.1%
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$188M
-156.4% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $57M | $163M | $189M | $144M | $67M |
| Depreciation & Amort. | $34M | $52M | $56M | $0 | $83M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$47M | -$66M | -$6M | -$66M | -$62M |
| Other Non-Cash Items | -$4M | -$19M | -$822K | $59M | -$9M |
| Operating Cash Flow | $39M | $129M | $238M | $137M | $80M |
| — Investing Activities — | |||||
| Capital Expenditures | -$14M | -$35M | -$10M | -$6M | -$49M |
| Acquisitions (Net) | -$2.7B | $0 | $0 | $0 | -$85M |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$11M | -$25M | -$34M | -$41M | $986 |
| Investing Cash Flow | -$2.7B | -$35M | -$44M | -$48M | -$134M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$24M | $0 | $0 | -$8M | -$235M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$92M | $17M | -$3M | $235M | -$24M |
| Financing Cash Flow | $2.9B | $17M | $16M | $228M | -$259M |
| Net Change in Cash | $230M | $117M | $201M | $334M | -$188M |
| Cash End of Period | $317M | $434M | $634M | $968M | $615M |
| Free Cash Flow | $25M | $95M | $194M | $90M | $68M |